PERSONALIZED MEDIA COMMUNICATIONS, LLC V. APPLE INC.
Before Reyna, Chen, and Stark. Appeal from the United States District Court for the Eastern District of Texas.
Summary: The district court did not abuse its...more
Collateral Estoppel Is Applicable in IPRs When the Question of Patentability Is the Same -
In Google LLC v. Hammond Development International, Inc. Appeal No. 21-2218, the Federal Circuit held that Google filed an IPR on...more
Restrictive Definitions Incorporated by Reference Do Not Necessarily Control for Later Patents in the Same Family -
In Finjan LLC v. Eset, LLC, Appeal No. 21-2093, the Federal Circuit held that specific definitions...more
Avoiding § 101 Eligibility Issues in Internet-Centric Method Claims -
In Weisner v. Google LLC, Appeal No. 21-2228, the Federal Circuit held that the specific implementation of an abstract idea, such as improving Internet...more
Duplicative-Litigation Doctrine: Proper Motion Practice is Essential to Avoid Dismissal of Duplicative Complaints -
In Arendi S.A.R.L. v. LG Electronics Inc., Appeal No. 21-1967, the Federal Circuit held that under the...more
In Thaler v. Vidal, Appeal No. 21-2347, the Federal Circuit held that, under the Patent Act, an “inventor” must be a natural person. Therefore, an AI system cannot be an inventor. ...more
In LG Electronics Inc. v. Immervision Inc., Appeal No. 21-2037, the Federal Circuit held that, where a reference contains an “obvious” error in a disclosure, even one not immediately apparent from the face of the disclosure,...more
Claims With Clerical Errors Can Be Judicially Corrected and Willfully Infringed -
In Pavo Solutions LLC v. Kingston Technology Company, Inc., Appeal No. 21-1834, the Federal Circuit held that a court can correct obvious...more
Somebody’s Wrong: PTAB Must Resolve Conflicting Factual Testimony During IPR -
In Google LLC v. IPA Technologies Inc., Appeal No. 21-1179, the Federal Circuit held that, for purposes of determining whether a reference was...more
6/20/2022
/ Appointments Clause ,
Arthrex Inc v Smith & Nephew Inc ,
Claim Construction ,
Constitutional Challenges ,
Federal Vacancies Reform Act ,
Google ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents
A Construction That Eliminates the Entire Scope of Dependent Claims Should Be Avoided -
Littelfuse, Inc. v. Mersen USA Ep Corp., Appeal No. 21-2013, the Federal Circuit vacated a claim construction that violated the doctrine...more
Claim Limitation Not Disclosed by Any Reference but Disclosed by “Proposed Combination” of References Is Obvious -
In Hoyt Augustus Fleming v. Cirrus Design Corporation, Appeal No. 21-1561, the Federal Circuit held that a...more
4/5/2022
/ Anticipation ,
Claim Construction ,
Claim Limitations ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Motion to Amend ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Sua Sponte ,
Substitute Claims
Ordered To Agree: Binding Settlement Agreement Provision Found Despite Absence of Singular, Executed Agreement -
In Plasmacam, Inc. v. Cncelectronics, LLC Appeal No. 21-1689, the Federal Circuit held that an agreement on...more
3/22/2022
/ Appeals ,
Binding Agreements ,
Broadest Reasonable Interpretation Standard ,
Claim Construction ,
Contract Terms ,
Estoppel ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Preliminary Injunctions ,
Prior Art ,
Settlement Agreements
避而不谈可能支持否定性权利要求限定 -
在 Novartis Pharmaceuticals 诉 Accord Healthcare Inc. 一案（上诉案件编号：21- 1070）中，联邦巡回上诉法院认为，一项对药物“速效剂量”避而不谈的专利申请，为要求不存在此类剂量的否定 性权利要求限制提供了书面说明支持。
...more
2/10/2022
/ Claim Construction ,
Indefiniteness ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
記述がないことがクレームの否定的限定のサポートと解釈できる場合がある
Federal Circuit は、Novartis Pharmaceuticals v. Accord Healthcare Inc. (Appeal No. 21-1070) に おいて、薬剤の「初回負荷用量」についての記述がない特許出願は、そのような用量がないことを要 求するクレームの否定的限定に記述によるサポートを提供していることになると判示した。
...more
2/10/2022
/ Claim Construction ,
Indefiniteness ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
January 2022 Federal Circuit Newsletter (Japanese) January 2022 Federal Circuit Newsletter (Chinese) Silence May Support Negative Claim Limitation In Novartis Pharmaceuticals v. Accord Healthcare Inc. Appeal No. 21-1070, the...more
2/9/2022
/ Claim Construction ,
Indefiniteness ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
Ranges for Interdependent and Interactive Components Can Be Tricky to Derive -
In Modernatx, Inc. v. Arbutus Biopharma Corporation, Appeal No. 20-2329, the Federal Circuit held that a presumption of obviousness based on...more
1/11/2022
/ AstraZeneca ,
Generic Drugs ,
Instrinsic Evidence ,
Intel ,
Inter Partes Review (IPR) Proceeding ,
Moderna Inc. ,
Mylan Pharmaceuticals ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Prior Art ,
Qualcomm
Venue and Pleading Infringement in Hatch-Waxman Litigation Turn on Location and Identity of ANDA Filer -
In Celgene Corp. v. Mylan Pharm. et al., Appeal No. 21-1154, the Federal Circuit held that in Hatch-Waxman...more
12/9/2021
/ Abbreviated New Drug Application (ANDA) ,
Apple ,
Article III ,
Biogen Idec ,
Dr. Reddy’s Labs. ,
Generic Drugs ,
Hatch-Waxman ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Mylan Pharmaceuticals ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Qualcomm ,
Standing ,
Written Descriptions
No Assembly, No Infringement – Federal Circuit Declines to Expand the “Final Assembler” Theory of Direct Infringement
In Acceleration Bay LLC v. Take-Two Interactive Software, Appeal No. 20-1700 the Federal Circuit held that...more
11/9/2021
/ Abstract Ideas ,
CLS Bank v Alice Corp ,
Computer-Related Inventions ,
Direct Infringement ,
Gaming ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Software
Arguments to the Patent Office That Contradict Information Submitted to the FDA Support an Inference of Deceptive Intent
In Belcher Pharmaceuticals v. Hospira, Inc., Appeal No. 20-1799, the Federal Circuit held that a...more
10/6/2021
/ Deceptive Intent ,
Evidence ,
Failure To Disclose ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Hospira ,
Inequitable Conduct ,
Intellectual Property Protection ,
Motion to Transfer ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Patents ,
Pharmaceutical Patents ,
Post-Grant Review ,
Prior Art ,
USPTO ,
Venue
It’s No Secret That a Related Company’s Physical Presence in a Jurisdiction May Not Be Enough For Proper Venue -
In Andra Group, LP v. Victoria’s Secret Stores, LLC, Appeal No. 20-2009, The Federal Circuit held that an...more
9/20/2021
/ Abstract Ideas ,
Eli Lilly ,
Improper Venue ,
Inter Partes Review (IPR) Proceeding ,
Jurisdiction ,
Nexus ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Physical Presence Test ,
Preamble ,
Principal Place of Business ,
Retailers ,
Teva Pharmaceuticals ,
Victoria Secret
District Court’s Pleading Standard Returns an Error Code in PS4 Battle -
In Bot M8 LLC v. Sony Corporation Of America, Appeal No. 20-2218, the Federal Circuit held that the district court’s view that infringement...more
8/18/2021
/ Amended Complaints ,
Claim Construction ,
Failure To State A Claim ,
Gaming ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pleading Standards ,
Prior Art ,
Qualcomm ,
Sony ,
Sua Sponte
Bulk-Filed Patent Applications Claiming Distant Priority Trigger Prosecution Laches -
In Hyatt v. Hirshfeld, Appeal No. 18-2390, the Federal Circuit held that the PTO met its burden to prove prosecution laches for bulk-filed...more
7/28/2021
/ Amazon Marketplace ,
Antitrust Provisions ,
Apple ,
Assignor Estoppel ,
Claim Construction ,
Compensation ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventions ,
Laches ,
NCAA ,
Patent Applications ,
Patent Infringement ,
Patents ,
Prior Art ,
Standalone Authority ,
Subject Matter Jurisdiction ,
USPTO ,
Venue
Court Grants Relief From Judgment After Witness Lies About the Bed of Its Own Making -
In Cap Export, LLC v. Zinus, Inc., Appeal No. 20-2087, the Federal Circuit held that a judgment and injunction were properly set aside...more
6/25/2021
/ Abstract Ideas ,
Federal Rules of Civil Procedure ,
Inventions ,
Inventors ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Personal Jurisdiction ,
Section 101 ,
Set-Asides ,
Witness Statements
Copying From a Copyrighted Computer Program May Be Fair Use to the Extent Needed to Promote Adoption of the Use of Accrued Talents in Creating a New Software Platform -
In Google LLC v. Oracle America, Inc., Appeal No....more
5/28/2021
/ Admissible Evidence ,
Copyright ,
Copyright Infringement ,
Fair Use ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Oracle v Google ,
Patent Royalties ,
Prior Art ,
SCOTUS ,
Software Developers ,
Source Code ,
Transformative Use
Corresponding Structure Snafu: Lack of Algorithm Renders Claims Indefinite -
In Rain Computing, Inc. v. Samsung Electronics Co. Ltd., Appeal No. 20-1646, the Federal Circuit held that the structure for performing a...more
4/27/2021
/ Algorithms ,
Claim Construction ,
Doctrine of Equivalents ,
Estoppel ,
Indefiniteness ,
Means-Plus-Function ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents